Intellicell Biosciences, Inc. Derivative Liability
Intellicell Biosciences, Inc. had Derivative Liability of $9.71 million as of 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2014-11-19
- 2014-09-30: Derivative Liability $9.71M.
- 2014-06-30: Derivative Liability $9.10M.
- 2014-03-31: Derivative Liability $15.13M; Derivative Liability as first filed $14.06M.
- 2013-12-31: Derivative Liability $6.96M; Derivative Liability as first filed $3.77M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2014-09-30 | $9.71M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $9.10M 10-Q · filed 2014-10-10 | |
| 2014-03-31 | $15.13M 10-Q · filed 2014-10-09 | $14.06M 10-Q · filed 2014-06-18 |
| 2013-12-31 | $6.96M 10-Q · filed 2014-11-19 | $3.77M 10-K · filed 2014-05-12 |
| 2013-09-30 | $6.88K 10-Q · filed 2013-11-25 | |
| 2013-06-30 | $82.46K 10-Q/A · filed 2013-10-18 | |
| 2013-03-31 | $3.77M 10-Q · filed 2014-06-18 | $332.02K 10-Q · filed 2013-10-01 |
| 2012-12-31 | $987.02K 10-K · filed 2014-10-09 | |
| 2012-03-31 | $987.02K 10-Q · filed 2013-10-01 | |
| 2011-12-31 | $14.79M 10-K · filed 2014-10-09 |